Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $896.38 | 31 | 91.5% |
| Travel and Lodging | $83.00 | 1 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $143.97 | 3 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $123.07 | 1 | $0 (2017) |
| BAXTER HEALTHCARE | $108.59 | 1 | $0 (2017) |
| Lilly USA, LLC | $100.85 | 7 | $0 (2021) |
| Medtronic, Inc. | $83.00 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $81.62 | 5 | $0 (2020) |
| Pacira Pharmaceuticals Incorporated | $65.24 | 1 | $0 (2018) |
| Organogenesis Inc. | $65.00 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $51.79 | 2 | $0 (2021) |
| Amgen Inc. | $44.87 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99.14 | 3 | Organogenesis Inc. ($65.00) |
| 2023 | $103.34 | 2 | Medtronic, Inc. ($83.00) |
| 2022 | $129.39 | 2 | ABBVIE INC. ($110.29) |
| 2021 | $162.87 | 10 | Lilly USA, LLC ($76.12) |
| 2020 | $132.82 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($81.62) |
| 2018 | $120.16 | 4 | Pacira Pharmaceuticals Incorporated ($65.24) |
| 2017 | $231.66 | 2 | BOSTON SCIENTIFIC CORPORATION ($123.07) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Organogenesis Inc. | PURAPLY FRANCHISE (Device) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: WOUND CARE | ||||||
| 06/19/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $34.14 | General |
| Category: UROLOGY | ||||||
| 01/23/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $35.35 | General |
| 07/19/2023 | Medtronic, Inc. | PIPELINE (Device) | Travel and Lodging | In-kind items and services | $83.00 | General |
| Category: Flow Diversion | ||||||
| 05/10/2023 | ZIMVIE INC. | TSX Implants (Device) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Dental | ||||||
| 05/26/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $110.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/19/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $19.10 | General |
| Category: Urology | ||||||
| 10/25/2021 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: NEPHROLOGY | ||||||
| 10/07/2021 | Lilly USA, LLC | REYVOW (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Neuroscience | ||||||
| 09/15/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: VIROLOGY | ||||||
| 07/28/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Neuroscience | ||||||
| 06/24/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: VIROLOGY | ||||||
| 05/26/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Neuroscience | ||||||
| 05/12/2021 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Bone Health | ||||||
| 03/27/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Neuroscience | ||||||
| 03/05/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Neuroscience | ||||||
| 02/23/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Bone Health | ||||||
| 12/17/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: DIABETES | ||||||
| 12/15/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Bone Health | ||||||
| 12/10/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: DIABETES | ||||||
| 10/28/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: DIABETES | ||||||
| 09/29/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: DIABETES | ||||||
| 08/26/2020 | Baudax Bio Inc. | ANJESO (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Pain Management | ||||||
| 08/20/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: DIABETES | ||||||
| 08/13/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 418 | 516 | $252,430 | $50,150 |
| 2022 | 9 | 381 | 601 | $280,820 | $63,505 |
| 2021 | 8 | 348 | 520 | $234,421 | $57,435 |
| 2020 | 8 | 309 | 376 | $134,234 | $34,052 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 223 | $71,740 | $20,755 | 28.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 132 | 132 | $54,555 | $14,363 | 26.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 63 | 63 | $69,300 | $9,494 | 13.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 15 | 15 | $17,250 | $2,903 | 16.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 24 | 24 | $37,920 | $2,055 | 5.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 28 | 40 | $1,000 | $380.80 | 38.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 19 | $665.00 | $199.98 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 303 | $96,960 | $28,715 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 131 | 131 | $54,140 | $15,289 | 28.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 37 | 37 | $40,700 | $5,620 | 13.8% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 13 | 56 | $17,920 | $5,121 | 28.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 15 | 15 | $17,250 | $2,875 | 16.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 22 | 22 | $34,760 | $1,844 | 5.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 12 | 13 | $11,050 | $1,728 | 15.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $5,340 | $1,605 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 12 | $2,700 | $706.80 | 26.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 127 | 291 | $83,920 | $28,057 | 33.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 98 | 98 | $40,243 | $10,888 | 27.1% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 30 | 30 | $25,232 | $4,387 | 17.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 33 | $12,635 | $4,247 | 33.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 19 | 19 | $9,920 | $3,056 | 30.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 15 | 15 | $16,460 | $2,772 | 16.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 17 | 17 | $18,100 | $2,732 | 15.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 16 | 17 | $27,911 | $1,295 | 4.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 99 | 164 | $39,930 | $12,274 | 30.7% |
About Dr. Muhammad Khan, MD
Dr. Muhammad Khan, MD is a Surgery healthcare provider based in Kingman, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508850116.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Khan, MD has received a total of $979.38 in payments from pharmaceutical and medical device companies, with $99.14 received in 2024. These payments were reported across 32 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($896.38).
As a Medicare-enrolled provider, Khan has provided services to 1,456 Medicare beneficiaries, totaling 2,013 services with total Medicare billing of $205,142. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Location Kingman, AZ
- Active Since 09/09/2005
- Last Updated 02/27/2014
- Taxonomy Code 208600000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508850116
Products in Payments
- WATCHMAN DEVICE (Device) $123.07
- CREON (Drug) $110.29
- Surgical Care - TachoSil (Biological) $108.59
- PIPELINE (Device) $83.00
- JARDIANCE (Drug) $81.62
- EMGALITY (Drug) $75.47
- EXPAREL (Drug) $65.24
- AQUABEAM SYSTEM (Device) $34.14
- MAVYRET (Drug) $33.68
- EVENITY (Biological) $31.62
- SAMSCA (Drug) $29.99
- PURAPLY FRANCHISE (Device) $29.65
- JYNARQUE (Drug) $21.80
- TSX Implants (Device) $20.34
- GEMTESA (Drug) $19.10
- Rayaldee (Drug) $13.67
- Prolia (Biological) $13.25
- ANJESO (Drug) $12.87
- TRULICITY (Drug) $12.83
- REYVOW (Drug) $12.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Kingman
Dr. James Mckinney, M.d, M.D
Surgery — Payments: $41,322
Dr. Mustafa Davis, M.d, M.D
Surgery — Payments: $480.99
Mr. Randall Beech, Md, MD
Surgery — Payments: $116.28
Hesham Sahawneh, Do, DO
Surgery — Payments: $89.39
Dr. Christopher Johnson, D.o, D.O
Surgery — Payments: $82.55
Dr. Rodney Courson, M.d, M.D
Surgery